Digital Health Interests Of Pharma Giants Boehringer Ingelheim, Takeda, Astrazeneca, Amgen And Roche
Posted Nov 5, 2021 from medicalfuturist.com
Pharmaceutical giants have the potential to shape the digital health landscape. In this series we investigated how big pharma prepares for the next level in medicine.
This third article, which will conclude the series, will peek into the digital health trends that pharma giants Boehringer Ingelheim, Takeda, AstraZeneca, Amgen and Roche have taken an interest in.
BI has also made moves to improve the patient side of the digital health equation.
Takeda: pushing for digital health innovation
Through TakedaSpark, Takeda aims to boost digital health innovation through new projects and partnerships.